Wockhardt Board to meet May 4 for Q4/FY26 results & fund-raising
Wockhardt Ltd. has scheduled a Board Meeting for Monday, May 4, 2026. The primary agenda includes considering and approving the Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31, 2026. Additionally, the Board will discuss and approve a proposal to raise funds through various instruments. These instruments may include Equity Shares, Global Depository Receipts (GDRs), American Depository Receipts (ADRs), Foreign Currency Convertible Bonds (FCCBs), and other convertible or non-convertible securities. The fund-raising could be executed through public or private offerings, including Qualified Institutions Placement (QIP) or preferential allotment, subject to shareholder approval. In compliance with insider trading regulations, the trading window for designated persons closed on April 1, 2026, and will reopen 48 hours after the financial results are declared.
Key Highlights
- Board meeting scheduled for May 4, 2026.
- Agenda includes approving Q4 and FY26 audited financial results.
- Board to consider raising funds via various equity and debt instruments.
- Fund-raising methods include QIP, preferential allotment, public/private offerings.
- Trading window closed from April 1, 2026, until results declaration.
Price Impact
More from WOCKPHARMA